INFU vs TECH · P/E 25, rev $134.9M vs P/E 65, rev $1.22B
InfuSystems Holdings Inc (INFU) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
InfuSystems Holdings Inc (INFU) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported INFU revenue for 2024-12-31 was $134.9M. Net income was $2.3M. Revenue was up 7.2% from 2023-12-31 to 2024-12-31. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
INFU currently screens at market cap $186.5M and trailing P/E 25.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the INFU and TECH stock pages for the full models.
Not investment advice.